TRIM

Serial Number 87671736
602

Registration Progress

Application Filed
Nov 3, 2017
Under Examination
May 21, 2019
Approved for Publication
Oct 2, 2018
Published for Opposition
Oct 2, 2018
Registered

Trademark Image

TRIM

Basic Information

Serial Number
87671736
Filing Date
November 3, 2017
Published for Opposition
October 2, 2018
Abandonment Date
June 17, 2021
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jun 29, 2021
Classes
005 042

Rights Holder

ARROWHEAD PHARMACEUTICALS, INC.

03
Address
177 E. Colorado Blvd., Suite 700
Pasadena, CA 91105

Ownership History

ARROWHEAD PHARMACEUTICALS, INC.

Original Applicant
03
PASADENA, CA

ARROWHEAD PHARMACEUTICALS, INC.

Owner at Publication
03
Pasadena, CA

Legal Representation

Attorney
Cynthia Johnson Walden

USPTO Deadlines

All Deadlines Cleared

All 8 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

42 events
Date Code Type Description Documents
Jun 29, 2021 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Jun 29, 2021 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Dec 16, 2020 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Dec 16, 2020 GNFR O FINAL REFUSAL E-MAILED Loading...
Dec 16, 2020 CNFR W SU - FINAL REFUSAL - WRITTEN Loading...
Nov 24, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 24, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 24, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 26, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 26, 2020 GNRT O NON-FINAL ACTION E-MAILED Loading...
May 26, 2020 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
May 15, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 14, 2020 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 14, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 13, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 1, 2020 IUAF S USE AMENDMENT FILED Loading...
May 1, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
May 1, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 1, 2020 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jan 2, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 2, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Nov 21, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 19, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 19, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 19, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 21, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 11, 2019 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Oct 26, 2018 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Oct 2, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 2, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 12, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 27, 2018 ALIE A ASSIGNED TO LIE Loading...
Aug 16, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 15, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 15, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 15, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 15, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 15, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 15, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 14, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 14, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 7, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical and medicinal preparations to treat cancer, hepatitis, cardiovascular disease, lung disease, liver disease, blood disease, cystic fibrosis and triglyceride disorders in humans
First Use Anywhere: 20180300
First Use in Commerce: 20180300
Class 042
Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Pharmaceutical research and development
First Use Anywhere: 20180300
First Use in Commerce: 20180300

Classification

International Classes
005 042